2-氯-4-嘧啶羧酰胺 | 22536-66-9

• 物质功能分类: 医药中间体 - 杂环化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪类
• 中文名称: 2-氯-4-嘧啶羧酰胺
• 中文别名: 2-氯嘧啶-4-酰胺
• 英文名称: 2-chloropyrimidine-4-carboxamide
• 英文别名: 2-Chlor-4-carbamoyl-pyrimidin；2-chloro-4-pyrimidinecarboxamide
• CAS: 22536-66-9
• 化学式: C₅H₄ClN₃O
• mdl: MFCD00234053
• 分子量: 157.559
• InChiKey: UXXQEVFRPLIOHJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  68.9
• 氢给体数：
  1
• 氢受体数：
  3

安全信息

• 海关编码：
  2933599090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  室温

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Chloropyrimidine-4-carboxamide
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Chloropyrimidine-4-carboxamide
CAS number: 22536-66-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels, refrigerated.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C5H4ClN3O
Molecular weight: 157.6

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

制备方法与用途

2-氯嘧啶-4-酰胺主要用于有机合成和作为医药中间体。

反应信息

• 作为反应物：
  描述：

  2-氯-4-嘧啶羧酰胺 在 N,N-二异丙基乙胺 、 三氟乙酸 作用下， 以 4-(dicyanomethylene)-2-methyl-6-(p-dimethylaminostyryl)-4H-pyran 、 乙腈 为溶剂， 反应 4.5h， 生成 1-(4-carbamoylpyrimidin-2-yl)piperidine-4-carboxylic acid
  参考文献：
  名称：

  [EN] ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF
  [FR] ISOXAZOLIDINES EN TANT QU'INHIBITEURS DE RIPK1 ET LEUR UTILISATION

  摘要：

  本发明涉及式I的异噁唑啉及其作为受体相互作用蛋白激酶1抑制剂的用途，例如用于治疗由RIP激酶（1）介导的疾病和紊乱，如类风湿性关节炎（RA）、牛皮癣、炎症性肠病（IBD）、克罗恩病或溃疡性结肠炎。

  公开号：

  WO2021245070A1
• 作为产物：
  描述：

  2-氯-4-嘧啶甲酸 在 ammonium hydroxide 、 氯化亚砜 作用下， 反应 0.5h， 以320 mg的产率得到2-氯-4-嘧啶羧酰胺
  参考文献：
  名称：

  [EN] ALKYNYL ALCOHOLS AND METHODS OF USE
  [FR] ALCOOLS ALCYNYLIQUES ET LEURS PROCÉDÉS D'UTILISATION

  摘要：

  该发明涉及以下式的化合物（0）：其中A1-A8，R4和R5分别具有如本文所述的含义。该式（0）的化合物及其药物组合物在治疗观察到NF-kB信号不良或过度激活的疾病和紊乱中是有用的。

  公开号：

  WO2015025026A1

文献信息

• FLAP MODULATORS
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：US20140221310A1

  公开（公告）日：2014-08-07

  The present invention relates to compounds of Formula (I), or a form thereof, wherein ring A, R 1 , L and R 2 are as defined herein, useful as FLAP modulators. The invention also relates to pharmaceutical compositions comprising compounds of Formula (I). Methods of making and using the compounds of Formula (I) are also within the scope of the invention.

  本发明涉及式（I）化合物，或其形式，其中环A，R1，L和R2如本文所定义，作为FLAP调节剂有用。该发明还涉及包含式（I）化合物的药物组合物。制备和使用式（I）化合物的方法也属于本发明的范围。
• N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists
  申请人：——

  公开号：US20020165241A1

  公开（公告）日：2002-11-07

  Compounds represented by Formula (I): 1 or pharmaceutically acceptable salts thereof, are effective as NMDA NR2B antagonists useful for relieving pain.

  由化学式（I）表示的化合物及其药学上可接受的盐，可作为NMDA NR2B拮抗剂，用于缓解疼痛。
• [EN] SUBSTITUTED PIPERAZINE COMPOUNDS AND METHODS AND USE THEREOF<br/>[FR] COMPOSÉS PIPÉRAZINIQUES SUBSTITUÉS, PROCÉDÉS ET UTILISATION ASSOCIÉS
  申请人：SUNSHINE LAKE PHARMA CO LTD

  公开号：WO2015169180A1

  公开（公告）日：2015-11-12

  Provided herein are novel piperazine compounds acting as selective serotonin reuptake inhibitors and/or the 5-HT1A receptor agonists. The invention also relates to the methods of preparing the compound and pharmaceutical composition, and the use of treating central nervous system dysfunction in mammals especially in humans.

  本文提供了作为选择性血清素再摄取抑制剂和/或5-HT1A受体激动剂的新型哌嗪化合物。该发明还涉及制备该化合物和药物组合物的方法，以及用于治疗哺乳动物中枢神经系统功能障碍，特别是人类的用途。
• [EN] MTH1 INHIBITORS FOR TREATMENT OF CANCER<br/>[FR] INHIBITEURS MTH1 POUR LE TRAITEMENT DU CANCER
  申请人：THOMAS HELLEDAYS STIFTELSE FÖR MEDICINSK FORSKNING

  公开号：WO2015187088A1

  公开（公告）日：2015-12-10

  A compound of formula I, (I) or a pharmaceutically-acceptable salt thereof. The compound is useful in the treatment of cancer.

  公式I的化合物(I)或其药用可接受的盐。该化合物在治疗癌症中很有用。
• 一种咪唑并吡啶或嘧啶衍生物的合成方法
  申请人：中国科学院大连化学物理研究所

  公开号：CN112851677A

  公开（公告）日：2021-05-28

  本发明属于合成技术领域，具体是一种咪唑并吡啶或嘧啶衍生物的合成方法。本发明以吡啶或嘧啶甲酸为合成子，经酰胺化、霍夫曼降解及环化反应得到咪唑并吡啶或嘧啶化合物，所得咪唑并吡啶或嘧啶衍生物能够发生进一步的转化生成功能化产物。该方法原料易得、操作简便、反应效率高、后处理方便，其官能团具有多样性。